Eligibility in a cohort of patients with hidradenitis suppurativa treated with bimekizumab: Lessons and pitfalls in a real-world setting

1. Ureña-Paniego, C.
2. Haselgruber, S.
3. Soto-Moreno, A.
4. Cuenca-Barrales, C.
5. Arias-Santiago, S.
6. Molina-Leyva, A.